How to Select the Right Bioanalysis CRO for your Program

For a biotech company, selecting the right bioanalysis CRO partner can make or break their program timeline. Nobody wants to be the next cautionary tale that plagues the industry of continuous delays, miscommunication or hidden fees. Bottom line: the right bioanalysis CRO becomes a true accelerator; the wrong one slows you down. But when everyone claims fast, credible results, what criteria should you use to make the right choice in selecting a bioanalysis CRO?

Join Ander Tallett, Co-Founder and Chief Operating Officer of Dash Bio, former Head of Procurement at Moderna, for an unfiltered examination of bioanalysis CRO selection challenges, red flags to avoid and importantly, solutions for securing a bioanalysis partner that matches your program’s pace. Drawing from extensive experience in building technology-driven R&D platforms, Ander will provide actionable insights that will help you select a bioanalysis CRO partner that improves predictability, accelerates program timeline and reduces risk.